Home
>
National Drug Code (NDC)
>
Nizatidine
Nizatidine - 0378-5150-05 - (nizatidine)
Drug Information of Nizatidine
| Product NDC: | 0378-5150 |
| Proprietary Name: | Nizatidine |
| Non Proprietary Name: | nizatidine |
| Active Ingredient(s): | 150 mg/1 & nbsp; nizatidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nizatidine
| Product NDC: | 0378-5150 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075806 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110504 |
Package Information of Nizatidine
| Package NDC: | 0378-5150-05 |
| Package Description: | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-5150-05) |
NDC Information of Nizatidine
| NDC Code | 0378-5150-05 |
| Proprietary Name | Nizatidine |
| Package Description | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-5150-05) |
| Product NDC | 0378-5150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nizatidine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110504 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | NIZATIDINE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
